Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure

European Journal of Heart Failure

Volumn 12, Issue 9, 2010, Pages 966-973

  Jankowska, Ewa A ^a,b,c   Drohomirecka, Anna ^b   Ponikowska, Beata ^a   Witkowska, Agnieszka ^b   Lopuszanska, Monika ^c   Szklarska, Alicja ^c   Borodulin Nadzieja, Ludmila ^a   Banasiak, Waldemar ^b   Poole Wilson, Philip A ^d   Ponikowski, Piotr ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

^c INSTITUTE OF ANTHROPOLOGY   (Poland)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Androgen; Dehydroepiandrosterone sulphate; Depression; Heart failure; Total testosterone

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC HEART FAILURE;

ADULT; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; DEPRESSION; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; POLAND; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TESTOSTERONE;

EID: 77955978743     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq108     Document Type: Article

References (31)

1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-598.
2. O'Donnell AB, Travison TG, Harris SS, Tenover JL, McKinlay JB. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2006;91:425-431.
3. Shores MM, Moceri VM, Sloan KL, Matsumoto AM, Kivlahan DR. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 2005;66:7-14.
4. Debigaré R, Marquis K, Côté CH, Tremblay RR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003;124:83-89.
5. Kalyani RR, Gavini S, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 2007;36:333-348.
6. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Anabolic deficiency in men with chronic heart failure. Prevalence and detrimental impact on survival. Circulation 2006;114:1829-1837.
7. Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail 2009;15:442-450.
8. Jankowska EA, Jakubaszko J, Cwynar A, Majda J, Ponikowska B, Kustrzycka-Kratochwil D, Reczuch K, Borodulin-Nadzieja L, Banasiak W, Poole-Wilson PA, Ponikowski P. Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail 2009;11:28-38.
9. Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999;84:573-577.
10. T'Sjoen GG, De Vos S, Goemaere S, Van Pottelbergh I, Dierick M, Van Heeringen C, Kaufman JM. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005;53: 636-642.
11. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann N Y Acad Sci 2003;1007:64-78.
12. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure. a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-1537.
13. Jünger J, Schellberg D, Müller-Tasch T, Raupp G, Zugck C, Haunstetter A, Zipfel S, Herzog W, Haass M. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005;7:261-267.
14. Angermann CE, Gelbrich G, Störk S, Fallgatter A, Deckert J, Faller H, Ertl G. MOOD-HF Investigators. Rationale and design of a randomised, controlled, multi-center trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 2007;9:1212-1222.
15. Parnowski T, Jenalczyk W. Inwentarz Depresji Becka w ocenie nastroju osob zdrowych i chorych na choroby afektywne. Psych Pol 1997;11:417-421.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
17. Westlake C, Dracup K, Fonarow G, Hamilton M. Depression in patients with heart failure. J Card Fail 2005;11:30-35.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
19. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005;7:803-808.
20. Onder G, Penninx BW, Cesari M, Bandinelli S, Lauretani F, Bartali B, Gori AM, Pahor M, Ferrucci L. Anemia is associated with depression in older adults: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2005;60: 1168-1172.
21. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 2006;17:146-150.
22. Kalender B, Ozdemir AC, Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 2006;102:115-121.
23. Schweiger U, Deuschle M, Weber B, Körner A, Lammers CH, Schmider J, Gotthardt U, Heuser I. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999;61:292-296.
24. Jozuka H, Jozuka E, Takeuchi S, Nishikaze O. Comparison of immunological and endocrinological markers associated with major depression. J Int Med Res 2003; 31:36-41.
25. Seidman SN, Miyazaki M, Roose SP. Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial. J Clin Psychopharmacol 2005;25: 584-588.
26. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 2005;62:154-162.
27. Kaneda Y, Fujii A. No relationship between testosterone levels and depressive symptoms in aging men. Eur Psychiatry 2002;17:411-413.
28. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 1999;54:129-137.
29. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol 2001;145:669-679.
30. Jockenhövel F, Minnemann T, Schubert M, Freude S, Hübler D, Schumann C, Christoph A, Gooren L, Ernst M. Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood. Aging Male 2009;12: 113-118.
31. Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009;70:1009-1016.